Get Access Share Export

Journals & Books Rounak Dubey

Cytotherapy
Volume 21, Issue 5, Supplement, May 2019, Page S60

207

A Novel approach for rbc depletion in abo incompatible

allogenic peripheral blood stem cell transplant using modified
hydroxyethyl starch method
R. Dubey 2 1, B. Asthana 1, N. Kushwaha 1, A. Pawar 3, 1, A. Biswas 1, A. Yadav 1, A. Marik 1

1 Immunohematology and Transfusion Medicine, Armed Forces Medical College, Pune, Maharashtra, India
2 Transfusion Medicine, All India Institute of Medical Sciences, Raipur, India
3 Transfusion Medicine, AFTC, New Delhi, India

Available online 24 May 2019.

Show less

https://doi.org/10.1016/j.jcyt.2019.03.439 Get rights and content

Background & Aim

Apheresis derived Peripheral Blood Stem cell(PBSC) products usually contain very few RBCs, so
RBC depletion is not routinely performed for these products. Though rare, an acute hemolytic
transfusion reaction was observed at the authors' Institution, when a blood group O positive
patient was transfused with PBSC product of group B, having relatively lower hematocrit (9. 6
%). After this adverse event, RBC depletion was carried out in this case as well as all other
subsequent Get Access
major Share
ABO-incompatible Export
PBSC Transplants, using a modified Hydroxy Ethyl Starch
(HES) sedimentation method.There is very limited literature which describes the process of RBC
depletion in PBSC product. There were multiple challenges faced and the procedure was carried
out after various modifications in the conventional method.

Methods, Results & Conclusion Method

During the process of removal of RBCs using 6 % HES, a major source for the loss of buffy coat
was identified as the formation of a Vortex, due to the relatively heavier weight of the buffy coat.
Various modifications, like ensuring a controlled release of sedimented RBCs, pausing the flow
of RBCs as soon as the Vortex appeared and breaking down the procedure into time-dependent
smaller phases, mitigated the loss of buffy coat and stem cells. The time taken for depletion was
increased to 4 hours, compared to 2 hours described for marrow-derived HSCs. Encouraged by
the success of result of first RBC depletion, it was carried out in four more ABO Incompatible
PBSC transplants.

Results
CD 34 count, TLC, and Hb of the product were measured before as well as after RBC depletion
(Table attached). Recovered CD 34 was found to be in the range of 75-80 % in all the cases. The
depletion process was highly effective as the final product had less than 1 gm% of hemoglobin.
No adverse transfusion reaction was observed during transfusion of PBSCs in any recipient.
Chimerism studies by VNTR analysis showed increasing donor chimerism. Successful
engraftment was achieved in 80% of these cases.

Conclusion
As automated platforms and cell sorters for RBC depletion in PBSC are not available at most of
the centers in developing counties, use of HES can be successfully employed using the modified
method suggested, especially in case of an unexpected acute hemolytic transfusion reaction.
Considering the limited literature available regarding this procedure, this case series provides
significant insight into the expected challenges and modifications to resolve them.

Previous Next
 Get Access Share Export
Recommended articles Citing articles (0)

View full text

Copyright © 2019 Published by Elsevier Inc.

About ScienceDirect Remote access Shopping cart Advertise Contact and support
Terms and conditions Privacy policy

We use cookies to help provide and enhance our service and tailor content and ads. By continuing
you agree to the use of cookies.
Copyright © 2019 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered
trademark of Elsevier B.V.